News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Refuses Again To Approve TAP Pharmaceutical Products Inc.'s Gout Drug


8/14/2006 8:24:49 AM

BOSTON, Aug 11 (Reuters) -- U.S. regulators refused to approve an experimental drug to treat gout being developed by Abbott Laboratories Inc. (ABT.N: Quote, Profile, Research) and Takeda Pharmaceuticals Co. (4502.T: Quote, NEWS, Research), according to a regulatory filing.

>>> Discuss This Story


Read at Reuters


comments powered by Disqus
Reuters
   
Gout

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES